Trends in Malaria Chemoprophylaxis Prescription in South Africa 1994 to 2000
Author(s) -
Peter A. Leggat,
David N. Dürrheim,
Lucille Blumberg
Publication year - 2006
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.2310/7060.2002.30173
Subject(s) - chemoprophylaxis , malaria , medicine , plasmodium falciparum , medical prescription , environmental health , chloroquine , immunology , surgery , pharmacology
The World Health Organization estimates that more than 300 million cases of malaria exist worldwide each year, resulting in more than 3 million deaths, with more than 1 million deaths of children in sub-Saharan Africa alone. Malaria is also a reemerging disease in some parts of Africa, including South Africa. Malaria prevention is multi-faceted with no single precaution offering complete protection. Taking chemoprophylaxis decreases the severity and frequency of death from malaria due to Plasmodium falciparum when compared with taking no chemoprophylaxis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom